Skip to main content
Photo of Gregory Aune M.D.
Photo of Gregory Aune M.D.
Our Doctors

Gregory Aune, M.D.

Pediatric Hematology Oncology
Adolescent & Young Adult Oncology
Request an Appointment

NOTE : If you're an existing patient, please connect via MyChart

  • About Me

    About Gregory Aune, M.D.

    Dr. Gregory J. Aune is the Greehey Distinguished University Chair for Cancer Survivorship in Children, the Stephanie Edlund Distinguished Professor of Pediatric Cancer Research, and a tenured associate professor of pediatrics at the University of Texas Health Science Center San Antonio.

    His experience in pediatric cancer spans over 29 years and encompasses his own patient experiences, research in experimental therapeutics, clinical care of pediatric oncology patients and childhood cancer advocacy. His interest in pediatric oncology began at age 16 when he was diagnosed with Hodgkin’s lymphoma. While fortunate to survive, the experiences he encountered as a patient initiated a path towards a research and clinical career aimed at developing less toxic chemotherapy regimens. His experience as a long-term survivor included open-heart surgery at age 35 to replace his aortic valve and bypass three blocked coronary arteries that were damaged by his teenage cancer therapies. This life-changing event initiated his research interest in cardiac disease.

    His training to become a successful physician scientist and pediatric oncologist has included time spent at some of the most well-respected oncology institutions in the United States, including M.D. Anderson Cancer Center, the National Cancer Institute and Johns Hopkins Hospital. 
    In the laboratory setting, Dr. Aune has a wide range of experience in the tumor biology and experimental therapeutics. Most recently, he has applied this  knowledge to both the in vitro and in vivo studies of the cardiovascular system from the level of the cardiac fibroblast to global cardiac function. His laboratory has successfully developed a novel pediatric mouse model of anthracycline-induced cardiac toxicity.

    Dr. Aune directs the Greehey Children’s Cancer Research Institute Shared Resource for Cardiac Function Assessment. He and his laboratory team are experts in the evaluation of cardiac function in mice by echocardiography, including advanced methods of analysis, such as ventricular strain. Collectively, expertise in these areas is supported by recent publications and the receipt of over half a million dollars annually in extramural funding from the St. Baldrick’s Foundation, Hyundai Corporation, the Pablove Foundation, the National Cancer Institute and the National Institute on Aging.

    Dr. Aune is the director of survivorship research for the South Texas Pediatric Cancer Survivorship program at University Hospital. In this role, he has established a cohort of long-term survivors of pediatric cancer. He serves as co-principal investigator and clinical director of the first investigator-initiated survivorship study in the South Texas region. This study is assessing the utility of using cardiac MRI to detect subclinical cardiac disease in survivors and is funded by the San Antonio Clinical and Translational Science Award. To date, 32 patients have been enrolled and MRI evaluation is ongoing. His expertise in the clinical arena is further supported by active participation in national task forces focusing on the cardiac effects of chemotherapy and radiation.

    Finally, Dr. Aune is a national leader in childhood cancer advocacy efforts. In San Antonio, he has been a leader in local fundraising and awareness efforts. Since 2010, he has spearheaded efforts by the St. Baldrick’s Foundation and For the Kids Dance Marathon at the University of Texas at San Antonio that have raised over $1 million for childhood cancer patients and research efforts. In September 2014, his appointment to the National Cancer Institute Council of Research Advocates (NCRA) was announced by NCI Director Dr. Harold Varmus at a White House briefing on childhood cancer.

    In May 2015, Dr. Aune addressed the 68th World Health Assembly in Geneva, Switzerland, and called on the World Health Organization to make childhood cancer a top global health priority. 

    • Male
    Languages Spoken
    • English

    Gregory Aune     |     Pediatric Hematology Oncology

    Quote Icon

    With a more basic understanding of how chemotherapy damages normal tissues such as the heart, we can begin to develop new medicines that protect vulnerable organs from the damage that results in late health effects in survivors.

  • Credentials


    • Assistant Professor of Pediatrics, University of Texas Health Science Center San Antonio
    • Greehey Distinguished University Chair for Cancer Survivorship in Children
    • Stephanie Edlund Distinguished Professor in Pediatric Cancer Research
    • American Board of Pediatrics
    • American Board of Pediatric Hematology-Oncology
    • American Board of General Pediatrics
    • Medical School: University of Texas Health Science Center at Houston, Houston, TX
    • Residency: Johns Hopkins University School of Medicine, Bailtimore, MD
    • Fellowship: University of Texas Health Science Center San Antonio, San Antonio, TX
  • Locations & Contact
  • Research & Publications
  • Clinical Trials

    Clinical Trials

    No Clinical Trials